Article
Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015.
Journal of clinical gastroenterology - 1 Aug 2018
Spradling Philip R, Xing Jian, Rupp Loralee B, Moorman Anne C, Gordon Stuart C, Lu Mei, Teshale Eyasu H, Boscarino Joseph A, Schmidt Mark A, Daida Yihe G, Holmberg Scott D
Abstract excerpt
BACKGROUND: Limited information is available describing the uptake of direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection among patients in general US health care settings. We determined the proportion of HCV-infected patients in the Chronic Hepatitis Cohort Study prescribed DAAs in 2014, who initiated treatment and identified characteristics associated with treatment initiation. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
